Skip to Content

Meloxicam Oral Suspension, USP (Canada)

This page contains information on Meloxicam Oral Suspension, USP for veterinary use.
The information provided typically includes the following:
  • Meloxicam Oral Suspension, USP Indications
  • Warnings and cautions for Meloxicam Oral Suspension, USP
  • Direction and dosage information for Meloxicam Oral Suspension, USP

Meloxicam Oral Suspension, USP

This treatment applies to the following species:
Manufacturer: AVL

Meloxicam 15 mg/mL

DIN 02441187

Veterinary Use Only

Warnings

Keep out of reach of children

Treated animals must not be used in food for at least 35 days after the latest treatment with this drug.

Do not use in lactating dairy cattle.

Do not use in calves to be processed for veal as a withdrawal period has not been established for pre-ruminating calves.

Nonsteroidal anti-inflammatory drug (NSAID) for cattle.

Active Ingredients

Each mL contains 15 mg meloxicam, USP.

Also contains 1.5 mg sodium benzoate as preservative.

Meloxicam Oral Suspension, USP Indications

For alleviation of pain and inflammation following surgical and band castration in cattle.

Dosage and Administration

Single oral administration of 1.0 mg meloxicam/kg body weight (10 mL/150 kg) should be administered approximately 1-2 hours prior to castration procedure. Using a dosing syringe, ensure the entire dose is administered at the back of the tongue to avoid spillage.

Contraindications

Do not use in animals with gastrointestinal disorders such as irritation and hemorrhage, impaired hepatic, cardiac or renal function and hemorrhagic disorders or where there is individual hypersensitivity to the product.

Do not administer concurrently with steroidal, other nonsteroidal anti-inflammatory drugs or with anti-coagulant agents.

Cautions: Avoid use in very severely dehydrated, hypovolemic or hypotensive animals which require parenteral rehydration, as there may be a potential risk of increased renal toxicity.

Use of anti-inflammatories in very young or debilitated animals may involve additional risk.

Treatment of calves with meloxicam before castration reduces post-operative pain. An anti-inflammatory alone will not provide adequate pain relief during the castration procedure. To obtain adequate pain relief during surgery co-medication with an appropriate analgesic is recommended. Concomitant use of NSAID’s with aminoglycoside antimicrobials in very young animals may result in renal toxicity.

Adverse Reactions

If you notice any adverse events please report them to the manufacturer or your veterinarian.

Pharmacology

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic and anti-pyretic properties. Plasma levels of meloxicam reached therapeutic values approximately two hour post administration. Therapeutic levels were seen for approximately 56 hours post dosing.

Storage

Store at 15-30°C.

Presentation: 150mL, 1L, and 4L plastic bottles

Product Codes: MXC150 (150mL); MXC1 (1L); MXC4 (4L)

Alberta Veterinary Laboratories Ltd., 411-19th Street SE, Calgary, AB T2E 6J7

NAC No.: 1602020.0

ALBERTA VETERINARY LABORATORIES LTD.
411-19TH STREET S.E., CALGARY, AB, T2E 6J7
Telephone:   403-456-2245
Toll-Free:   877-456-2755
Fax:   403-207-6074
Website:   www.avetlabs.com
Email:   avl_contact@avetlabs.com
Every effort has been made to ensure the accuracy of the Meloxicam Oral Suspension, USP information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide